[
    [
        {
            "time": "2018-03-15",
            "original_text": "Morgan Stanley Declares Quarterly Dividends on Its Preferred Stock",
            "features": {
                "keywords": [
                    "Morgan Stanley",
                    "Quarterly Dividends",
                    "Preferred Stock"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Morgan Stanley Declares Quarterly Dividends on Its Preferred Stock",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 9
            }
        },
        {
            "time": "2019-06-17",
            "original_text": "Pfizer Expands in Cancer With $10.6 Billion Deal for Array",
            "features": {
                "keywords": [
                    "Pfizer",
                    "Cancer",
                    "Deal",
                    "Array"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Pfizer Expands in Cancer With $10.6 Billion Deal for Array",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 10,
                "Impact": 9,
                "Duration": 9,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        },
        {
            "time": "2019-08-20",
            "original_text": "Stock Investors Are Getting Smarter as the Threats Stack Up",
            "features": {
                "keywords": [
                    "Stock Investors",
                    "Threats"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "none",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "Stock Investors Are Getting Smarter as the Threats Stack Up",
                "Correlation": 4,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 3,
                "Duration": 4,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-04-25",
            "original_text": "Morgan Stanley Adds Six New $10,000 Minimum Impact Portfolios to Investing with Impact Platform",
            "features": {
                "keywords": [
                    "Morgan Stanley",
                    "Impact Portfolios",
                    "Investing"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Morgan Stanley Adds Six New $10,000 Minimum Impact Portfolios to Investing with Impact Platform",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-07-10",
            "original_text": "Morgan Stanley Capital Partners Completes Investment in Ovation Fertility",
            "features": {
                "keywords": [
                    "Morgan Stanley",
                    "Capital Partners",
                    "Investment",
                    "Ovation Fertility"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Morgan Stanley Capital Partners Completes Investment in Ovation Fertility",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 5,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-11-22",
            "original_text": "China Is Mad at UBS. Welcome to Emerging Markets",
            "features": {
                "keywords": [
                    "China",
                    "UBS",
                    "Emerging Markets"
                ],
                "sentiment_score": -0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "global markets"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "China Is Mad at UBS. Welcome to Emerging Markets",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]